Genotype polymorphisms of GGCX, NQO1, and VKORC1 genes associated with risk susceptibility in patients with large-artery atherosclerotic stroke

Clinica Chimica Acta

Volumn 411, Issue 11-12, 2010, Pages 840-845

  Shyu, Hann Yeh ^a,b   Fong, Chin Shih ^c,d   Fu, Yi Ping ^e   Shieh, Jia Ching ^f   Yin, Jiu Haw ^a   Chang, Ching Yi ^a   Wang, Hsiao Wei ^f,g   Cheng, Chun Wen ^f,g  

^a TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coagulation factors; Genotype polymorphism; GGCX; NQO1; Stroke; VKORC1

Indexed keywords

ARGININE; BLOOD CLOTTING FACTOR; GAMMA GLUTAMYL HYDROLASE; GLYCINE; MENADIONE EPOXIDE; PHYTOMENADIONE OXIDE; PROLINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SERINE; GLUTAMYL CARBOXYLASE; LIGASE; MENADIONE EPOXIDASE; MIXED FUNCTION OXIDASE; NQO1 PROTEIN, HUMAN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GGCX GENE; HEART ATRIUM FIBRILLATION; HOMOZYGOSITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NQO1 GENE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SMOKING; VKORC1 GENE; AGED; ATHEROSCLEROSIS; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PATHOLOGY; STROKE;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CARBON-CARBON LIGASES; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; MIXED FUNCTION OXYGENASES; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; RISK FACTORS; STROKE;

EID: 78751613019     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2010.02.071     Document Type: Article

References (45)

1. Bevan S., Porteous L., Sitzer M., Markus H.S. Phosphodiesterase 4D gene, ischemic stroke, and asymptomatic carotid atherosclerosis. Stroke 2005, 36:949-953.
2. Deleu D., Hamad A.A., Kamram S., El Siddig A., Al Hail H., Hamdy S.M. Ethnic variations in risk factor profile, pattern and recurrence of non-cardioembolic ischemic stroke. Arch Med Res 2006, 37:655-662.
3. Lacut K., Larramendy-Gozalo C., Le Gal G., Duchemin J., Mercier B., Gourhant L, et al. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study. J Thromb Haemost 2007, 5:2020-2024.
4. Kalaria R.N., Low W.C., Oakley A.E., Slade J.Y., Ince P.G., Morris C.M., et al. CADASIL and genetics of cerebral ischaemia. J Neural Transm Suppl 2002, 63:75-90.
5. Alberts M.J., Tournier-Lasserve E. Update on the genetics of stroke and cerebrovascular disease 2004. Stroke 2005, 36:179-181.
6. Coon H., Xin Y., Hopkins P.N., Cawthon R.M., Hasstedt S.J., Hunt S.C. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet 2005, 117:444-451.
7. Hajat C., Tilling K., Stewart J.A., Lemic-Stojcevic N., Wolfe C.D. Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke 2004, 35:1562-1567.
8. Lohmussaar E., Gschwendtner A., Mueller J.C., Org T., Wichmann E., Hamann G., et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36:731-736.
9. Saidi S., Slamia L.B., Mahjoub T., Ammou S.B., Almawi W.Y. Association of PAI-1 4G/5G and -844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case-control study. J Stroke Cerebrovasc Dis 2007, 16:153-159.
10. Watzka M., Nebel A., El Mokhtari N.E., Ivandic B., Muller J., Schreiber S., et al. Functional promoter polymorphism in the VKORC1 gene is no major genetic determinant for coronary heart disease in Northern Germans. Thromb Haemost 2007, 97:998-1002.
11. Cortellaro M., Baldassarre D., Cofrancesco E., Tremoli E., Colombo A., Boschetti C., et al. Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease. Stroke 1996, 27:450-454.
12. He M., Wen Z., He X., Xiong S., Liu F., Xu J., et al. Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002, 107:223-228.
13. Jood K., Ladenvall P., Tjarnlund-Wolf A., Ladenvall C., Andersson M., Nilsson S., et al. Fibrinolytic gene polymorphism and ischemic stroke. Stroke 2005, 36:2077-2081.
14. Furie B., Bouchard B.A., Furie B.C. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 1999, 93:1798-1808.
15. Arnold M.L., Lichy C., Werner I., Radbruch A., Wagner S., Grond-Ginsbach C. Single nucleotide polymorphisms in the VKORC1 gene and the risk of stroke in the Southern German population. Thromb Haemost 2008, 100:614-617.
16. Watzka M., Westhofen P., Hass M., Marinova M., Potzsch B., Oldenburg J. Polymorphisms in VKORC1 and GGCX are not major genetic determinants of vitamin K-dependent coagulation factor activity in Western Germans. Thromb Haemost 2009, 102:418-420.
17. Wannamethee S.G., Lowe G.D., Whincup P.H., Rumley A., Walker M., Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002, 105:1785-1790.
18. Yip P.K., Jeng J.S., Lee T.K., Chang Y.C., Huang Z.S., Ng S.K., et al. Subtypes of ischemic stroke. A hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 1997, 28:2507-2512.
19. Adams H.P., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
20. Sirma S., Agaoglu L., Yildiz I., Cayli D., Horgusluoglu E., Anak S., et al. NAD(P)H:quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia. Pediatr Blood Cancer 2004, 43:568-570.
21. Harada S., Fujii C., Hayashi A., Ohkoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 2001, 288:887-892.
22. Rieder M.J., Reiner A.P., Rettie A.E. Gamma-glutamyl carboxylase (GGCX) tagSNPs have limited utility for predicting warfarin maintenance dose. J Thromb Haemost 2007, 5:2227-2234.
23. Wallin R. Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect. Biochem J 1986, 236:685-693.
24. Linder M.W., Bon Homme M., Reynolds K.K., Gage B.F., Eby C., Silvestrov N., et al. Interactive modeling for ongoing utility of pharmacogenetic diagnostic testing: application for warfarin therapy. Clin Chem 2009, 55. 1861-8.
25. Herman D., Peternel P., Stegnar M., Breskvar K., Dolzan V. The influence of sequence variations in factor VII, gamma-glutamyl carboxylase and vitamin K epoxide reductase complex genes on warfarin dose requirement. Thromb Haemost 2006, 95:782-787.
26. Kimura R., Miyashita K., Kokubo Y., Akaiwa Y., Otsubo R., Nagatsuka K., et al. Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients. Thromb Res 2007, 120:181-186.
27. Buil A., Soria J.M., Souto J.C., Almasy L., Lathrop M., Blangero J., et al. Protein C levels are regulated by a quantitative trait locus on chromosome 16: results from the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project. Arterioscler Thromb Vasc Biol 2004, 24:1321-1325.
28. Limdi N.A., Beasley T.M., Crowley M.R., Goldstein J.A., Rieder M.J., Flockhart D.A., et al. VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans. Pharmacogenomics 2008, 9:1445-1458.
29. Curtis D., Gurling H.M. Using a dummy quantitative variable to deal with multiple affection categories in genetic linkage analysis. Ann Human Gene 1991, 55:321-327.
30. Ananth C.V., Kleinbaum D.G. Regression models for ordinal responses: a review of methods and applications. Int J Epidemiol 1997, 26:1323-1333.
31. Ernster L., Lind C., Rase B. A study of the DT-diaphorase activity of warfarin-resistant rats. Eur J Biochem 1972, 25:198-206.
32. Kereveur A., Leclercq M., Trossaert M., Dupeyron J.P., Parent F., Horellou M.H., et al. Vitamin K metabolism in a patient resistant to vitamin K antagonists. Haemostasis 1997, 27:168-173.
33. Kimura R., Kokubo Y., Miyashita K., Otsubo R., Nagatsuka K., Otsuki T., et al. Polymorphisms in vitamin K-dependent gamma-carboxylation-related genes influence interindividual variability in plasma protein C and protein S activities in the general population. Int J Hematol 2006, 84:387-397.
34. Wang T.L., Li H.L., Tjong W.Y., Chen Q.S., Wu G.S., Zhu H.T., et al. Genetic factors contribute to patient-specific warfarin dose for Han Chinese. Clin Chim Acta 2008, 396:76-79.
35. Wang Y., Zhang W., Zhang Y., Yang Y., Sun L., Hu S., et al. VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection). Circulation 2006, 113:1615-1621.
36. Rieder M.J., Reiner A.P., Gage B.F., Nickerson D.A., Eby C.S., McLeod H.L., et al. Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose. N Engl J Med 2005, 352:2285-2293.
37. Vecsler M., Loebstein R., Almog S., Kurnik D., Goldman B., Halkin H., et al. Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin. Thromb Haemost 2006, 95:205-211.
38. Mast H., Thompson J.L., Lin I.F., Hofmeister C., Hartmann A., Marx P., et al. Cigarette smoking as a determinant of high-grade carotid artery stenosis in Hispanic, black, and white patients with stroke or transient ischemic attack. Stroke 1998, 29:908-912.
39. Sacco R.L., Boden-Albala B., Abel G., Lin I.F., Elkind M., Hauser W.A., et al. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke 2001, 32:1725-1731.
40. He Y., Lam T.H., Jiang B., Wang J., Sai X., Fan L., et al. Passive smoking and risk of peripheral arterial disease and ischemic stroke in Chinese women who never smoked. Circulation 2008, 118:1535-1540.
41. Leone A. Smoking, haemostatic factors, and cardiovascular risk. Curr Pharm Des 2007, 13:1661-1667.
42. Berliner J.I., Rybicki A.C., Kaplan R.C., Monrad E.S., Freeman R., Billett H.H. Elevated levels of Factor XI are associated with cardiovascular disease in women. Thromb Res 2002, 107:55-60.
43. Wang X., Fu S., Freedman R.S., Kavanagh J.J. Venous thromboembolism syndrome in gynecological cancer. Int J Gynecol Cancer 2006, 16(Suppl 1):458-471.
44. Ruigrok Y.M., Slooter A.J., Rinkel G.J., Wijmenga C., Rosendaal F.R. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding. Acta Neurochir 2010, 152:257-262.
45. Li N., He Z., Xu J., Liu F., Deng S., Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res Bull 2010, 81:38-42.